Krueger Christopher W's Form 4/A amendment
AmendedVentyx Biosciences, Inc. (VTYX) · filed May 4, 2023
- Accession no.
- 0001209191-23-027314
- Filed
- May 4, 2023
- Trade date
- Apr 3, 2023
- Filing delay
- 31 days
- Rule 10b5-1 plan
- Not checked
- Original filed
- Apr 5, 2023
This filing lists 3 non-derivative transactions. It carries over 2 transactions from the original filing that it did not restate. Open-market sales total $493.2K. It was filed 31 days after the trade.
This amendment restates part of 0001209191-23-023472 (filed Apr 5, 2023). The transactions it did not restate still count and are listed below.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Krueger Christopher WCIK 0001394208 | Officer (Chief Business Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 3, 2023 | Common Stock | MOption exerciseAcquired | +7,972 | $3.54 | +$28,220.88 | 290,642 | Direct | |
| Apr 3, 2023 | Common Stock | MOption exerciseAcquired | +475 | $8.04 | +$3,819 | 291,117 | Direct | |
| Apr 3, 2023 | Common Stock | SSaleDisposed | −15,000 | $32.88F3 | −$493,200 | 276,117 | Direct |
Carried over from the original filing
This amendment restates only part of the original filing. The original's other transactions still stand, and the trade tables on Livermore count them under this amendment.
From 0001209191-23-023472 (filed Apr 5, 2023).
Derivative securities (Table II)
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 3, 2023 | Common Stock | MOption exerciseDisposed | −7,972 | $0.00 | $0 | 0 | Direct | |
| Apr 3, 2023 | Common Stock | MOption exerciseDisposed | −475 | $0.00 | $0 | 170,176 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
This amendment is being filed to correct the transaction date reported in the Form 4 filed April 5, 2023.
- F2
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 28, 2022.
- F3
Represents the weighted average share price of an aggregate total of 15,000 shares sold in the price range of $32.5744 to $33.495. The reporting owner undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.